ARTICLE | Company News
GSK, Battelle formulation deal
November 20, 2001 8:00 AM UTC
Battelle Pulmonary Therapeutics (Columbus, Ohio) will use its Mystic electrohydrodynamic pulmonary delivery technology to formulate an undisclosed compound for GlaxoSmithKline (GSK; LSE:GSK). ...